In addition, further experiments are required to explore whether the mechanisms of lapatinib-induced cell death in leukemia are different than the mechanisms that kill cancer cell lines that die in much lower concentrations, such as breast cancer cells with higher levels of ErbB2 expression [10], [12], [24], [25]. The gene discussed is ERBB2; the disease is leukemia.